Informing the pharmaceutical drug development and commercialization industry.
Cary, N.C. – February 20, 2014 – Industry Standard Research (ISR) released a new market research report this week entitled “Brazil: Clinical Development Country Profile.” The report provides insight into the clinical trial environment in Brazil, sponsor and service provider activities in the region, as well as the Brazilian population health status.
“With a population exceeding 200 million and a rapidly growing pharmaceutical market, the opportunities for clinical development activities in Brazil are substantial,” explained Andrew Schafer, President of ISR.
ISR’s new report leverages insight from senior development personnel within global CROs, Brazilian health statistics, and exhaustive secondary research and analysis to provide drug sponsors and their service providers a novel, strategic tool to assess the opportunity in Brazil. “Data contained in this report can be used by sponsors and service providers to develop more accurate strategic clinical development plans that take into account target populations, historic clinical trial metrics, and input from domestic service providers as to the strengths and weaknesses of conducting trials in Brazil,” Schafer continues.
What you’ll learn from “Brazil: Clinical Development Country Profile:”
- How population health status, regulations and clinical trial activity, and international and domestic company partnerships make Brazil one of the top emerging global pharmaceutical markets
- Insights from domestic service provider organizations on conducting clinical trials in Brazil
- Health statistics in Brazil, including life expectancy, disease incidence and prevalence, and health expenditure
- Names and contact details for domestic and international service providers operating in Brazil
More information about this report is available on ISR’s website at https://isrreports.com/product/brazil-clinical-development-country-profile/.
About Industry Standard Research
Industry Standard Research is the premier, full service market research provider to the pharma and pharma services industries. With over a decade of experience, ISR delivers an unmatched level of domain expertise. For more information about our off-the-shelf intelligence and custom research offerings, please visit the company’s Web site at www.ISRreports.com, email info@ISRreports.com, or follow us on Twitter @ISRreports.
